Long Position on ETON @ $12.00 on 11/26/2024 (Fundamentals)

Eton Pharmaceuticals, Inc. (ETON), a special

ty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. 

T

he company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Entry Point: $12.00

Trading Range: $3.03 - $12.54

Stop Loss: $11.40

Target Price: $13.20

Position closed on 12/2/2024 at price of $13.95 with a 16.25% gain in 6 days.

Back to Portfolio